NK-30424A

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNK-30424A
Drug Alias NameNK-30424BNK-30424ANK-30424-BS-2
ClassificationSmall molecules
Mechanisms of ActionTNF alpha synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsMultiple SclerosisArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Kayaku Co Ltd
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A